Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial. (Q44243863)

From Wikidata

Jump to navigation Jump to search

scientific article published on 14 May 2014

Language	Label	Description	Also known as
English	Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial.	scientific article published on 14 May 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827136%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827136%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

chemoradiotherapy

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

David Cunningham

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827136%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827136%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

David Sebag-Montefiore

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827136%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

author name string

R Glynne-Jones

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827136%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

L Kadalayil

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827136%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

H M Meadows

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827136%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

J I Geh

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827136%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

C Lowdell

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827136%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

R James

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827136%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

S Beare

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827136%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

R Begum

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827136%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

J A Ledermann

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827136%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

ACT II Study Group

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827136%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

14 May 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827136%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827136%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827136%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827136%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1616-1622

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827136%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU188

21 January 2018

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU188

21 January 2018

Chemoradiotherapy of anal carcinoma: survival and recurrence in an unselected national cohort

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU188

21 January 2018

Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU188

21 January 2018

Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU188

21 January 2018

Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU188

21 January 2018

Curative-intent radiation therapy in anal carcinoma: quality of life and sphincter function.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU188

21 January 2018

Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU188

21 January 2018

Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU188

21 January 2018

US intergroup anal carcinoma trial: tumor diameter predicts for colostomy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU188

21 January 2018

Capturing data on colostomy formation in anal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU188

21 January 2018

Cause-specific colostomy rates after radiotherapy for anal cancer: a Danish multicentre cohort study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU188

21 January 2018

Defunctioning stomas prior to chemoradiation for anal cancer are usually permanent

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU188

21 January 2018

Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU188

21 January 2018

The dose-response of the anal sphincter region--an analysis of data from the MRC RT01 trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU188

21 January 2018

Identifiers

10.1093/ANNONC/MDU188

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827136%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24827136%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44243863&oldid=2108874309"